Park Avenue Securities’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Buy
2,395
+25
+1% +$11.5K 0.01% 849
2026
Q1
$1.14M Sell
2,370
-533
-18% -$273K 0.01% 753
2025
Q4
$1.63M Sell
2,903
-9
-0.3% -$5.11K 0.01% 620
2025
Q3
$1.5M Buy
2,912
+37
+1% +$16.2K 0.01% 707
2025
Q2
$902K Buy
2,875
+126
+5% +$37.8K 0.01% 816
2025
Q1
$838K Buy
2,749
+48
+2% +$16.1K 0.01% 682
2024
Q4
$897K Buy
2,701
+760
+39% +$258K 0.01% 822
2024
Q3
$648K Sell
1,941
-295
-13% -$112K 0.01% 876
2024
Q2
$921K Buy
2,236
+5
+0.2% +$1.98K 0.01% 705
2024
Q1
$902K Sell
2,231
-34
-2% -$12K 0.01% 711
2023
Q4
$694K Buy
2,265
+371
+20% +$100K 0.01% 772
2023
Q3
$459K Buy
+1,894
New +$484K 0.01% 873
2023
Q1
Sell
-945
Closed -$201K 981
2022
Q4
$201K Buy
+945
New +$189K ﹤0.01% 1141
2022
Q2
Sell
-1,473
Closed -$241K 1150
2022
Q1
$241K Buy
1,473
+325
+28% +$53.6K ﹤0.01% 1031
2021
Q4
$250K Sell
1,148
-62
-5% -$13K ﹤0.01% 980
2021
Q3
$229K Sell
1,210
-16
-1% -$2.92K ﹤0.01% 954
2021
Q2
$217K Sell
1,226
-382
-24% -$65.9K ﹤0.01% 964
2021
Q1
$264K Sell
1,608
-468
-23% -$71.6K 0.01% 827
2020
Q4
$289K Sell
2,076
-53
-2% -$6.68K 0.01% 705
2020
Q3
$238K Sell
2,129
-272
-11% -$31.5K 0.01% 658
2020
Q2
$223K Buy
+2,401
New +$204K 0.01% 605

Other funds holding MEDP

Park Avenue Securities's MEDP Position: Q2 2026 in Review

Park Avenue Securities increased its Medpace (MEDP) stake by 1.1% in Q2 2026, buying an estimated $11.5K and bringing the position to 2,395 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #849.

Park Avenue Securities first reported a position in MEDP in Q2 2020 and has held it in 21 quarters since. The position peaked at $1.63M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Park Avenue Securities held 2,395 shares of Medpace worth $1.27M as of Q2 2026.
  • Park Avenue Securities bought 25 Medpace shares in Q2 2026, an estimated $11.5K.
  • Medpace made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #849 holding.
  • Park Avenue Securities first reported a position in Medpace in Q2 2020 and has held it in 21 quarters since.
  • Park Avenue Securities's Medpace position peaked at $1.63M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.